Cognetivity Neurosciences LtdCanadian Securities Exchange:CGNView on OTC Pink - Limited Information
- LAST PRICE0.0100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots0.0050/ 115
- Open / Previous Close--- / 0.0100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cognetivity Neurosciences Ltd | 885.9K | -0.1x | --- |
Verisante Technology Inc | 659.1K | -4.9x | --- |
TruTrace Technologies Inc | 763.5K | -0.4x | --- |
Pangenomic Health Inc | 1.3M | -0.1x | --- |
MyndTec Inc | 1.1M | -1.0x | --- |
EvokAI Creative Labs Inc | 1.5M | -0.1x | --- |
Company Information
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Contact Information
- Headquarters
- Suite 1430, 800 West Pender St.VANCOUVER, BC, Canada V6C 2V6
- Phone
- 604-363-0411
- Fax
- 604-688-9588
Executives
- Chief Executive Officer, Director
- Sina Habibi
- Chief Financial Officer, Chief Operating Officer, Corporate Secretary, Director
- Thomas Sawyer
- Chief Scientific Officer
- Seyed Madhi Khaligh Razavi
- Chief Medical Officer, Director
- Christos Kalafatis
- Director
- Desmond Balakrishnan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $885.9K |
|---|---|
Revenue (TTM) | $99.0K |
Shares Outstanding | 88.6M |
Cognetivity Neurosciences Ltd does not pay a dividend. | |
Beta | -0.21 |
EPS | $-0.08 |
Book Value | $-0.12 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 9.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,192.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
